Skip to main content

Pharmacy Chains To Pay $878M Over Opioid Crisis In Ohio

Pharmacy Chains To Pay $878M Over Opioid Crisis In Ohio

Pharmacy Chains To Pay $878M Over Opioid Crisis In Ohio

Introduction

CVS Health Corp, Walgreens Boots Alliance Inc and Walmart Inc are required to fund a settlement plan of $878 million which will address the companies' role in the opioid crisis in two Northeast Ohio counties.

In November, a federal jury ruled that the companies played a major role in creating a public nuisance in Ohio's Lake and Trumbull counties by flooding the counties with addictive prescription pain pills.

The attorney representing the counties said that the counties are now looking forward to getting an $878 million five-year plan to deal with the opioid crisis. The statement was made by the attorney in front of U.S. Judge Dan Polster in Cleveland, where the trial was ongoing.

CVS, Walgreens and Walmart responded to the ruling by stating that they deny the claims made by the counties and would appeal the November verdict. The companies have planned to buy back unused prescription opioid drugs in the two counties by implementing a one-year program. The companies even argued that Ohio's public nuisance law demands the companies to stop only the nuisance identified by the jury, which includes an oversupply of the drugs.

The companies argued that they should not be forced to cover costs related to illegal drug use if they must buy the drugs back. The counties argued that the oversupply of prescription drugs resulted in creating a market for illegal drugs like heroin and synthetic fentanyl.

According to the data provided by the government, the opioid epidemic in the U.S. has resulted in more than 500,000 overdose deaths over two decades. A recent wave of proposed settlements indicates that drugmakers, distributors and pharmacy chains face more than 3,300 opioid lawsuits against them over the opioid crisis.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!